Clinical Trial Update: Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases [Phase 1]

View source ↗

Summary

Phase I trial evaluating lithium during whole-brain radiotherapy for patients with brain metastases; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Central Nervous System Tumors

Drugs mentioned

• Lithium (Lithium carbonate)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects | Phase 1 | Status: TERMINATED